Uterine Microbiota Play a Key Role in Implantation and Pregnancy Success in in vitro Fertilization
According to a new study in the American Journal of Obstetrics and Gynecology
According to a new study in the American Journal of Obstetrics and Gynecology
Philadelphia, PA, December 6, 2016
Endometrial microbiota (bacteria in the uterine cavity) play an important role in determining whether women are able to get pregnant via in vitro fertilization (IVF), according to a new study published in the American Journal of Obstetrics and Gynecology.
“The uterine cavity has been considered sterile,” explained lead investigator Carlos Simón, MD, PhD, of Igenomix Spain, and the Department of Obstetrics and Gynecology of the University of Valencia, Spain. “Our team sought to test the existence of endometrial microbiota that differs from that of the vagina. We assessed its hormonal regulation and analyzed the impact of the endometrial microbial community on reproductive outcome in patients undergoing IVF.”
To identify the existence of an endometrial microbiota, investigators evaluated paired samples of endometrial and vaginal fluid obtained from 13 fertile women in pre-receptive and receptive phases within the same menstrual cycle. To investigate the hormonal regulation of the endometrial microbiota during the acquisition of endometrial receptivity, endometrial fluid was collected at pre-receptive and receptive phases within the same cycle from 22 fertile women. Finally, the reproductive impact of an altered endometrial microbiota in endometrial fluid was assessed by implantation, ongoing pregnancy, and live birth rates in 35 infertile patients undergoing IVF with a receptive endometrium diagnosed using the endometrial receptivity array based on gene expression.
When paired endometrial fluid and vaginal fluid samples from the same patients were examined, different bacterial communities were detected between the two sites in some women. The microbiota in the endometrial fluid was classified as Lactobacillus-dominated or non-Lactobacillus-dominated microbiota. There was no evidence that steroid hormones played a role in determining the composition of the microbial community in the endometrium. On the other hand, women with a non-Lactobacillus-dominated microbiota and a receptive endometrium had a significantly lower rate of implantation, pregnancy, and live birth than patients with a Lactobacillus-dominated microbiota.
In an accompanying commentary, Linda C. Giudice, MD, PhD, Distinguished Professor and reproductive endocrinologist at the University of California San Francisco, noted that reproductive success is clearly not solely defined by endometrial histology and gene expression. The ongoing revolution in technology, multiple -omics, and multidimensional data analysis has opened the window of implantation to a greater level of scrutiny. It is time to investigate the endometrial microbiome and expand research to its virome, fungome, epigenome, and metabolome, she wrote.
Putting the significance of this study into perspective, Roberto Romero, MD, DMedSci, Chief of the Perinatology Research Branch of NICHD/NIH and Editor-in-Chief for Obstetrics of the American Journal of Obstetrics and Gynecology, commented that “the endometrial cavity is not sterile and normally contains bacteria; however, whether bacteria within the cavity play a role in successful reproduction has been unknown to this point. The pioneering work of the team of Professor Simónnow shows, for the first time, that colonization of the uterine cavity with some bacteria (non Lactobacillus-dominated) affects the success of in vitro fertilization, pregnancy rates, and live births. This brings hope that diagnostic tests to examine the microbial composition of the uterine cavity may be valuable in assessing the likelihood of success of IVF. Moreover, it raises the question of whether targeted treatment with antimicrobial agents or probiotics may be useful in improving reproductive success, and suggests that successful reproduction may depend on a host-microbial relationship in the endometrial cavity, unknown before this time.”
In addition to Igenomix and Valencia University, Lifesequencing and Biopolis (Scientific Park of Valencia University) contributed to this study. Endometrial samples were obtained from patients from IVI Valencia.
Notes for editors
The article is "Evidence that the endometrial microbiota has an effect on implantation success or failure," by Inmaculada Moreno, PhD; Francisco M. Codoñer, PhD; Felipe Vilella, PhD; Diana Valbuena, MD, PhD; Juan F. Martinez-Blanch, PhD; Jorge Jimenez-Almazán, PhD; Roberto Alonso; Pilar Alamá, MD, PhD; Jose Remohí, MD, PhD; Antonio Pellicer, MD, PhD; Daniel Ramon, PhD; Carlos Simón, MD, PhD, (doi: 10.1016/j.ajog.2016.09.075). It appears in the American Journal of Obstetrics and Gynecology, volume 215, issue 6 (December 2016), published by Elsevier, openly available at www.ajog.org/article/S0002-9378(16)30782-7/fulltext.
“Commentary: Challenging dogma – the endometrium has a microbiome with functional consequences!” by Linda C. Giudice, MD, PhD, (doi: 10.1016/j.ajog.2016.09.085), openly available at www.ajog.org/article/S0002-9378(16)30792-X/fulltext.
Full text of these articles is available to credentialed journalists upon request. Contact Eileen Leahy at +1 732-238-3628 or email@example.com to obtain copies. Journalists wishing to interview the authors may contact Carlos Simón, MD, PhD, at +34 963905310, Ext:18530 or 18102, +34 963902522, firstname.lastname@example.org. Journalists wishing to reach Linda C. Giudice, MD, PhD, for comment may contact her at Linda.Giudice@ucsf.edu. Roberto Romero may be contacted at email@example.com.
About The American Journal of Obstetrics and Gynecology
The American Journal of Obstetrics and Gynecology, known as “The Gray Journal,” presents coverage of the entire spectrum of the field, from the newest diagnostic procedures to leading-edge research. The Journal provides comprehensive coverage of the specialty, including maternal-fetal medicine, reproductive endocrinology/infertility, and gynecologic oncology. It also publishes the annual meeting papers of several of its eight sponsoring societies, including the Society for Maternal-Fetal Medicine and the Society of Gynecologic Surgeons.
The American Journal of Obstetrics and Gynecology's 2015 Impact Factor is 4.681. The journal ranks third in Eigenfactor score, continues to be first in total citations, and is the number 3 journal in the Obstetrics & Gynecology category according to the 2015 Journal Citation Reports®, published by Thomson Reuters, 2016. The journal has also been recognized as one of the 100 most influential journals in Biology & Medicine over the last 100 years, as determined by the BioMedical & Life Sciences Division of the Special Libraries Association (2009).
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com